Sharp M - Search Results

1

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.

Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Hata A, et al. Among authors: sharp m. N Engl J Med. 2002 Jul 4;347(1):26-34. doi: 10.1056/NEJMoa013441. N Engl J Med. 2002. PMID: 12097537 Free article. Clinical Trial.

2

Nader S, Bergen R, Sharp M, Arvin AM. Nader S, et al. Among authors: sharp m. J Infect Dis. 1995 Jan;171(1):13-7. doi: 10.1093/infdis/171.1.13. J Infect Dis. 1995. PMID: 7798653 Clinical Trial.

3

Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.

Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Asanuma H, et al. Among authors: sharp m. J Infect Dis. 2000 Mar;181(3):859-66. doi: 10.1086/315347. J Infect Dis. 2000. PMID: 10720505

4

Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.

Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM. Frey CR, et al. Among authors: sharp ma. J Infect Dis. 2003 Jul 1;188(1):40-52. doi: 10.1086/375828. Epub 2003 Jun 23. J Infect Dis. 2003. PMID: 12825169

5

Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.

Klein NP, Holmes TH, Sharp MA, Heineman TC, Schleiss MR, Bernstein DI, Kemble G, Arvin AM, Dekker CL. Klein NP, et al. Among authors: sharp ma. Vaccine. 2006 Aug 14;24(33-34):5913-8. doi: 10.1016/j.vaccine.2006.04.060. Epub 2006 May 9. Vaccine. 2006. PMID: 16759768

6

Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus.

Arvin AM, Sharp M, Moir M, Kinchington PR, Sadeghi-Zadeh M, Ruyechan WT, Hay J. Arvin AM, et al. Among authors: sharp m. Viral Immunol. 2002;15(3):507-16. doi: 10.1089/088282402760312377. Viral Immunol. 2002. PMID: 12479399

7

Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.

Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Wilson A, et al. Among authors: sharp m. J Infect Dis. 1992 Jan;165(1):119-26. doi: 10.1093/infdis/165.1.119. J Infect Dis. 1992. PMID: 1309369

8

Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.

Sharp M, Terada K, Wilson A, Nader S, Kinchington PE, Ruyechan WT, Hay J, Arvin AM. Sharp M, et al. J Infect Dis. 1992 May;165(5):852-8. doi: 10.1093/infdis/165.5.852. J Infect Dis. 1992. PMID: 1314871 Clinical Trial.

9

Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.

Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J. Arvin AM, et al. Among authors: sharp m. J Immunol. 1991 Jan 1;146(1):257-64. J Immunol. 1991. PMID: 1670603

10

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.

Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Bergen RE, et al. Among authors: sharp m. Viral Immunol. 1991 Fall;4(3):151-66. doi: 10.1089/vim.1991.4.151. Viral Immunol. 1991. PMID: 1725699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

739 results

Search Page

Filters